from their blog...but the link in the post is the P53 Press Release by CTIX
May 30, 2017 Cellceutix Anti-Cancer Drug Candidate’s p53 Activity in Acute Myeloid Leukemia to be Presented by Independent Researchers at the 2017 European Hematology Association Annual Meeting
blog from investor (similar to iHub posting), not KSS... blogs are in response to KSS section:
"ONCOTUTORIAL and many investors list top 10 biotechs...
By Dr. KSS MD PhD, June 28, 2017
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.]"
So does not necessarily reflect KSS's view. No comments by him so far.